These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4740684)

  • 21. [Silymarin action in liver diseases].
    Hammerl H; Pichler O; Studlar M
    Med Klin; 1971 Sep; 66(36):1204-8. PubMed ID: 5096207
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental research on the hepatoprotective activity of flavonoids isolated from Amorpha fructiosa].
    Kloutek E; Popov A; Drenska D; Uzunov P
    Eksp Med Morfol; 1985; 24(2):50-4. PubMed ID: 4065006
    [No Abstract]   [Full Text] [Related]  

  • 23. [Letter: Silymarine against acute degenerative hepatitis in mice induced by FV 3. Experimental study of its activity].
    Kirn A; Gut JP; Gendrault JL
    Nouv Presse Med; 1974 Sep; 3(31):1960. PubMed ID: 4374682
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of silymarin on the isolated perfused rat liver poisoned by phalloidin].
    Weil G; Frimmer M
    Arzneimittelforschung; 1970 Jun; 20(6):862-3. PubMed ID: 5468908
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G; Mingrino GC; Cagnetta G; Copponi V
    Clin Ter; 1980 Jan; 92(1):33-58. PubMed ID: 7449307
    [No Abstract]   [Full Text] [Related]  

  • 26. Stabilization of isolated rat liver plasma membranes by treatment in vitro with silymarin.
    Ramellini G; Meldolesi J
    Arzneimittelforschung; 1974 May; 24(5):806-8. PubMed ID: 4408361
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of silimarine on the hepatotoxic capacity of butter-yellow combined with a rice diet, in rats].
    Oporto Ruĩz T; Alemany Ontiveros JR; Sãnchez de la Cuesta F; De Alarcõn ; Monfort Albelda R; Aznar Lõpez J
    Rev Clin Esp; 1972 Dec; 127(6):1095-100. PubMed ID: 4197211
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of a new liver therapeutic (ES 914) on allylalcohol damaged rat liver].
    Renker H; Chariatte N; Dittrich A; Wegmann A
    Arzneimittelforschung; 1972 Jun; 22(6):1009-11. PubMed ID: 5068346
    [No Abstract]   [Full Text] [Related]  

  • 29. [The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)].
    Barbarino F; Suciu A; Cotutiu C; Ban A
    Wien Klin Wochenschr; 1977 Feb; 89(3):90-5. PubMed ID: 189515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of the anti-hepatotoxic effect of silymarin in CCl4-and deoxycholate-induced liver damage in the rat].
    Schriewer H; Badde R; Roth G; Rauen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:157-8. PubMed ID: 4740686
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of convaflavine on functional status of liver in experimental hepatitis].
    Bezruk PI; Zborovskaia EA; Fedorova LI; Madievskiĭ IuM; Kolesnikova GS
    Farmakol Toksikol; 1969; 32(1):65-8. PubMed ID: 5770318
    [No Abstract]   [Full Text] [Related]  

  • 33. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O; Benelli L; Saraceni F; Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1980 Oct; 95(2):157-64. PubMed ID: 7471652
    [No Abstract]   [Full Text] [Related]  

  • 34. Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat.
    Valenzuela A; Aspillaga M; Vial S; Guerra R
    Planta Med; 1989 Oct; 55(5):420-2. PubMed ID: 2813578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the regenerative capacity of the liver in rats subjected to partial hepatectomy and treated with silymarin.
    Magliulo E; Carosi PG; Minoli L; Gorini S
    Arzneimittelforschung; 1973 Jan; 23():Suppl:161-7. PubMed ID: 4740690
    [No Abstract]   [Full Text] [Related]  

  • 36. [Membrane protectors and silymarin in hepatology therapy].
    Grossi F; Viola F
    Clin Ter; 1981 Jan; 96(1):11-23. PubMed ID: 7016408
    [No Abstract]   [Full Text] [Related]  

  • 37. [The pharmacodynamics of hepatic protectors from the lady's-thistle (Silybum marianum)].
    Rumiantseva ZhN
    Vrach Delo; 1991 May; (5):15-9. PubMed ID: 1866906
    [No Abstract]   [Full Text] [Related]  

  • 38. [The antagonistic effect of silybin-dihemisuccinate on disorders of phosphatidyl synthesis in the rat liver].
    Schriewer H; Weinhold F; Stöcker K; Rauen HM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():309-11. PubMed ID: 1029194
    [No Abstract]   [Full Text] [Related]  

  • 39. Liver protection by silymarin: in vitro effect on dissociated rat hepatocytes.
    Ramellini G; Meldolesi J
    Arzneimittelforschung; 1976; 26(1):69-73. PubMed ID: 947182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of silimarine on activity of lysosomal proteinases in the liver and kidneys during tetramethylthiuram disulfide administration].
    Tabagari SI; Shubitidze TM; Abdushelishvili GV
    Vopr Med Khim; 1988; 34(5):110-3. PubMed ID: 3064406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.